Literature DB >> 26884928

microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4.

Xueqin Li1, Xinsheng Liu1, Jun Fang1, Huazhuang Li1, Jingchun Chen1.   

Abstract

Abnormal expression of microRNAs plays important functions in osteosarcoma. The aim of this study was to investigate expression, functions and molecular mechanisms of microRNA-363 in osteosarcoma. Quantitative Real-time PCR was used to detect the expression level of microRNA-363 in osteosarcoma tissue samples and cell lines. After transfection, CCK8 assay, cell migration and invasion assay, western blot and Dual-Luciferase report assay were performed in human osteosarcoma cells. According to the results, we found that microRNA-363 was down-regulated in osteosarcoma tissues and cell lines. In addition, low expression level of microRNA-363 was associated with tumor size, clinical stage and distant metastasis. Moreover, microRNA-363 targeted MAP2K4 to inhibit osteosarcoma cell growth, migration and invasion. In conclusion, microRNA-363 played a tumor suppressive role in osteosarcoma by directly targeting MAP2K4. These findings indicated that microRNA-363 may have therapeutic value in treating osteosarcoma.

Entities:  

Keywords:  MAP2K4; growth; metastasis; microRNA-363; osteosarcoma

Year:  2015        PMID: 26884928      PMCID: PMC4723773     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  38 in total

Review 1.  Non-coding RNAs, epigenetics and complexity.

Authors:  Fabrício F Costa
Journal:  Gene       Date:  2008-01-15       Impact factor: 3.688

2.  The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis.

Authors:  Shinnosuke Tsuji; Yoshihiro Kawasaki; Shiori Furukawa; Kenzui Taniue; Tomoatsu Hayashi; Masumi Okuno; Masaya Hiyoshi; Joji Kitayama; Tetsu Akiyama
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

3.  MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells.

Authors:  Peng Zhou; Gang Huang; Yuanyin Zhao; Dan Zhong; Zhizhen Xu; Yijun Zeng; Yan Zhang; Song Li; Fengtian He
Journal:  Cell Signal       Date:  2014-03-12       Impact factor: 4.315

4.  miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis.

Authors:  Jingbo Qiao; Sora Lee; Pritha Paul; Lauren Theiss; Joshua Tiao; Lan Qiao; Andrew Kong; Dai H Chung
Journal:  Surgery       Date:  2013-06-24       Impact factor: 3.982

Review 5.  How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.

Authors:  Dennis P M Hughes
Journal:  Cancer Treat Res       Date:  2009

6.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark Krailo; Eugenie S Kleinerman; Donna Betcher; Mark L Bernstein; Ernest Conrad; William Ferguson; Mark Gebhardt; Allen M Goorin; Michael B Harris; John Healey; Andrew Huvos; Michael Link; Joseph Montebello; Helen Nadel; Michael Nieder; Judith Sato; Gene Siegal; Michael Weiner; Robert Wells; Lester Wold; Richard Womer; Holcombe Grier
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

Review 7.  Primary bone osteosarcoma in the pediatric age: state of the art.

Authors:  Alessandra Longhi; Costantino Errani; Massimiliano De Paolis; Mario Mercuri; Gaetano Bacci
Journal:  Cancer Treat Rev       Date:  2006-07-24       Impact factor: 12.111

8.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

9.  Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.

Authors:  Yool Cho; Gu-Hee Jung; So-Hak Chung; Ji-Yeon Kim; Young Choi; Jae-Do Kim
Journal:  Clin Orthop Surg       Date:  2011-02-15

10.  miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2.

Authors:  Chenglin Yang; Chunying Hou; Hepeng Zhang; Dewei Wang; Yan Ma; Yunqi Zhang; Xiaoyan Xu; Zhenggang Bi; Shuo Geng
Journal:  Int J Mol Sci       Date:  2013-12-31       Impact factor: 5.923

View more
  7 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Astrocyte-Derived Exosomal microRNA miR-200a-3p Prevents MPP+-Induced Apoptotic Cell Death Through Down-Regulation of MKK4.

Authors:  Norshalena Shakespear; Masato Ogura; Junko Yamaki; Yoshimi Homma
Journal:  Neurochem Res       Date:  2020-02-04       Impact factor: 3.996

3.  Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment.

Authors:  Ankush Sharma; Caterina Cinti; Enrico Capobianco
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

4.  Modulation of Host miRNAs Transcriptome in Lung and Spleen of Peste des Petits Ruminants Virus Infected Sheep and Goats.

Authors:  Aruna Pandey; Amit R Sahu; Sajad A Wani; Shikha Saxena; Sonam Kanchan; Vaishali Sah; Kaushal K Rajak; Alok Khanduri; Aditya P Sahoo; Ashok K Tiwari; Bina Mishra; D Muthuchelvan; Bishnu P Mishra; Raj K Singh; Ravi K Gandham
Journal:  Front Microbiol       Date:  2017-06-26       Impact factor: 5.640

Review 5.  What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?

Authors:  Gaia Palmini; Francesca Marini; Maria Luisa Brandi
Journal:  Molecules       Date:  2017-03-07       Impact factor: 4.411

6.  The circular RNA circ0005654 interacts with specificity protein 1 via microRNA-363 sequestration to promote gastric cancer progression.

Authors:  Cui Yang; Shengjin Han
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma.

Authors:  Yi Li; Jinying Lu; Furong Bai; Yanan Xiao; Yiran Guo; Ziming Dong
Journal:  Biomed Res Int       Date:  2018-03-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.